Analysts expect Fennec Pharmaceuticals Inc. to report revenue of 18.31 M for Q3 26, against a range of 17.44 M to 19.17 M. The most recent reported quarter, Q2 26, came in at 17.87 M, a 4.0% beat against the 17.18 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 6.97 M | 7.92 M | 8.75 M | 9.65 M | 12.46 M | 13.78 M | 15.10 M | 17.87 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 10.14 M | 8.50 M | 8.90 M | 9.58 M | 12.83 M | 16.53 M | 13.47 M | 18.03 M | 19.17 M | 22.65 M | 24.93 M | 23.89 M | 28.84 M | 27.77 M | 35.28 M | 37.48 M | ||||||||||
| Low Estimate | 8.40 M | 7.96 M | 7.94 M | 8.32 M | 11.02 M | 14.18 M | 12.66 M | 16.33 M | 17.44 M | 21.24 M | 22.12 M | 21.88 M | 25.18 M | 24.23 M | 31.64 M | 33.59 M | ||||||||||
| Consensus Estimate | 9.27 M | 8.23 M | 8.42 M | 8.95 M | 11.92 M | 15.35 M | 13.06 M | 17.18 M | 18.31 M | 21.95 M | 23.53 M | 22.88 M | 27.01 M | 26.00 M | 33.46 M | 35.54 M |
Analysts expect Fennec Pharmaceuticals Inc. to report earnings per share of 0.08 for Q3 26, against a range of 0.08 to 0.08. The most recent reported quarter, Q2 26, came in at 0.05, a 150.0% beat against the 0.02 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.21 | -0.06 | -0.04 | -0.11 | -0.02 | -0.17 | 0.01 | 0.05 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.08 | -0.11 | -0.08 | -0.03 | -0.02 | 0.04 | -0.04 | 0.02 | 0.08 | 0.15 | 0.15 | 0.23 | 0.27 | 0.29 | 0.40 | 0.42 | ||||||||||
| Low Estimate | -0.10 | -0.13 | -0.10 | -0.03 | -0.02 | 0.04 | -0.04 | 0.02 | 0.08 | 0.13 | 0.13 | 0.19 | 0.23 | 0.27 | 0.34 | 0.38 | ||||||||||
| Consensus Estimate | -0.09 | -0.12 | -0.09 | -0.03 | -0.02 | 0.04 | -0.04 | 0.02 | 0.08 | 0.14 | 0.14 | 0.21 | 0.25 | 0.28 | 0.37 | 0.40 |
Pull Wall Street consensus for Fennec Pharmaceuticals Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=FENC&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "FENC", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=FENC&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();